Fig. 7From: ARL3 is downregulated and acts as a prognostic biomarker in gliomaARL3 negatively regulated angiogenesis and influenced infiltrating immune cells in GBM. a IVY GAP (http://glioblastoma.alleninstitute.org/static/home) was employed to analyze the locations of ARL3 in glioblastoma anatomic structures. b Pearson’s correlation analysis showed that ARL3 was negatively correlated with several proangiogenic genes (COL4A1, ANXA2, VEGFA, MMP14) in TCGA (HG-UG133A). Data from TIMER (c) and TCIA (d) indicated that ARL3 influenced the proportion of infiltrating immune cells in GBMBack to article page